Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
McKesson
US Department of Justice
Boehringer Ingelheim
Chubb
Dow
Argus Health
Baxter
QuintilesIMS

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,696,159

« Back to Dashboard

Which drugs does patent 7,696,159 protect, and when does it expire?

Patent 7,696,159 protects ALDARA and is included in one NDA.

Protection for ALDARA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
Summary for Patent: 7,696,159
Title:Treatment for basal cell carcinoma
Abstract:The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
Inventor(s): Owens; Mary L. (Cottage Grove, MN), Fox; Terrance L. (Oakdale, MN), Ginkel; Angela M. (St. Paul, MN)
Assignee: Graceway Pharmaceuticals, LLC (Bristol, TN)
Application Number:12/008,961
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 7,696,159

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Medicis ALDARA imiquimod CREAM;TOPICAL 020723-001 Feb 27, 1997 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cipla
Citi
Accenture
Argus Health
Harvard Business School
US Department of Justice
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot